Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences第一季度每股收益1.70美元,超过预期(1.91美元),销售额1758万美元超过602万美元的预期
Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $(1.91) by 189.01 percent. This is a 124.64 percent increase over losses of $(6.90) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $6.02 million by 192.09 percent. This is a 100.27 percent increase over sales of $8.78 million the same period last year.
Precision BioSciences(纳斯达克股票代码:DTIL)公布的季度收益为每股1.70美元,比分析师普遍预期的1.91美元(1.91美元)高出189.01%。与去年同期每股亏损6.90美元(6.90)相比,增长了124.64%。该公司公布的季度销售额为1758万美元,比分析师普遍预期的602万美元高出192.09%。这比去年同期的878万美元的销售额增长了100.27%。